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Abstract
Recent developments in molecular diagnostic tools have led to the easy and rapid detection of a large number of rhinovirus (HRV) strains.
However, the lack of clinical and epidemiological data hampers the interpretation of these diagnostic ﬁndings. From October 2009 to
January 2011, we conducted a prospective study in hospitalized children from whom samples were taken for the detection of respiratory
viruses. Clinical, epidemiological and microbiological data from 644 patients with 904 disease episodes were collected. When HRV tested
positive, strains were further characterized by sequencing the VP4/VP2 region of the HRV genome. HRV was the single respiratory virus
detected in 254 disease episodes (28%). Overall, 99 different serotypes were detected (47% HRV-A, 12% HRV-B, 39% HRV-C). Patients
with HRV had more underlying pulmonary illness compared with patients with no virus (p 0.01), or patients with another respiratory virus
besides HRV (p 0.007). Furthermore, cough, shortness of breath and a need for oxygen were signiﬁcantly more present in patients with
HRV infection. Particularly, patients with HRV-B required extra oxygen. No respiratory symptom, except for oxygen need, was predictive
of the presence of HRV. In 22% of HRV-positive disease episodes, HRV infection was hospital acquired. Phylogenetic analysis revealed
several clusters of HRV; in more than 25% of these clusters epidemiological information was suggestive of transmission within speciﬁc
wards. In conclusion, the detection of HRV may help in explaining respiratory illness, particular in patients with pulmonary co-morbidities.
Identifying HRV provides opportunities for timely implementation of infection control measures to prevent intra-hospital transmission.
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Introduction
In recent years, human rhinoviruses (HRVs) have been
increasingly recognized as a potential cause of acute otitis
media, bronchiolitis, asthma and pneumonia in children [1–3].
The development of sensitive and rapid molecular techniques
markedly improved the detection rate of HRV and revealed
the high genetic diversity. Over 150 serotypes of HRV have
been described, classiﬁed into three main species: HRV-A,
HRV-B and HRV-C [4]. HRV-C is the most recently
discovered species and is thought to contribute more to
recurrent wheezing and exacerbations of asthma compared
with HRV-A and HRV-B [1,5]. Also, recently published data
suggest that HRV-A and HRV-C cause more severe illness
than HRV-B, with the greatest virulence during the winter [6].
Currently, molecular diagnostics are increasingly integrated
into routine practice, allowing detection and quantiﬁcation of
HRV, and also raising questions about their value in direct
patient care and infection control. We performed a hospital-
based prospective study to determine the clinical, epidemio-
logical and viral characteristics associated with HRV infection
in children.
ª2013 The Authors
Clinical Microbiology and Infection ª2013 European Society of Clinical Microbiology and Infectious Diseases
ORIGINAL ARTICLE VIROLOGY
Materials and Methods
Patients and sample collection
In October 2009 a prospective study of respiratory infections
in hospitalized children was initiated at the University Medical
Center Groningen (UMCG), the Netherlands. The UMCG is a
tertiary referral hospital with more than 1300 beds in the
northern region of the country. Demographic, clinical and
microbiological data were systematically collected from all
children under 18 years of age, from whom respiratory
samples were taken for the detection of 15 respiratory viruses
(inﬂuenza A/B, respiratory syncytial virus A/B, coronavirus
229E/NL63/OC43, para-inﬂuenzavirus type 1–4, metapneumo-
virus, adenovirus, bocavirus and rhinovirus). Samples positive
for HRV were further characterized by sequence analysis of
the VP4/VP2 region. Information on the presence of bacterial
respiratory pathogens was included when bacteriological
culture was performed on the same day, 1 day before or
1 day after the virological sample was taken.
Clinical data were collected using a standardized case
record form, with items regarding the presence of an
underlying chronic illness (pulmonary, cardiovascular, gastro-
intestinal or neurological) and/or immune suppression (trans-
plantation, malignancy or immune suppressive therapy), clinical
symptoms (fever, cough, shortness of breath, otitis media,
wheezing, vomiting, diarrhoea, need for oxygen or mechanical
ventilation), treatment (antibiotics, antivirals or inhalation
therapy), clinical diagnosis (upper respiratory tract infection
(pharyngitis, coryza or otitis media) or lower respiratory tract
infection (pneumonia, bronchiolitis, exacerbation of asthma or
croup)) and outcome. Underlying pulmonary illness included
asthma, congenital pulmonary illness or anatomic malforma-
tions, cystic ﬁbrosis and bronchopulmonary disease. Cardio-
vascular disease was divided into inborn or acquired heart
disease. Patients with partial resection of the bowel or failure
to thrive, and those who were waiting for a liver transplan-
tation, were categorized as having gastrointestinal disease as an
underlying illness. Neurological disease was not further
speciﬁed.
Epidemiological data were gathered to determine whether
the respiratory infection was community or hospital acquired,
including measures that were taken in the hospital to prevent
further transmission of respiratory viruses. Hospital-acquired
HRV infection was deﬁned as a ﬁrst day of illness 2 or more
days after admission to the hospital. Infection control
measures consisted of a combination of droplet and contact
precautions (gown, gloves and mask for healthcare workers
during patient care, and patient in a single room) and were
installed when HRV was detected.
The study was approved by the local Medical Ethical
Committee of the UMCG. Informed consent was obtained
from a parent or guardian.
Real-time PCR and sequencing
The majority of samples (91%) arrived at the laboratory within
1 day after collection. Samples were divided into aliquots and
stored at 4°C if PCR testing was performed on the same or
the next day. Longer storage was carried out at 80°C. In
general, PCR testing was performed on a daily basis, providing
results within 48 h after arrival of the sample at the laboratory.
All respiratory samples, nasopharyngeal swabs, aspirates or
sputum, were tested by a laboratory-developed (LDT) real-
time PCR, as has been described elsewhere [7]. For rhinovirus
detection, a real-time LDT-PCR was introduced using the
SuperScript III Platinum One-Step qRT-PCR Kit, (Life
technologies, Carlsbad, CA, USA). All reactions were per-
formed with Phocine Distemper Virus as an internal control in
a total volume of 25 lL containing 12.5 lL of 29 reactionmix,
0.5 lL SuperScript III RT/Platinum Taq mix, 0.5 lL of 1:10
Rox reference dye, 300 nM of each forward primer, 600 nM
reverse primer and 100 nM of each probe, and 5 lL of
genomic RNA template. Primers and probes used are listed in
Table 1. The addition of this large set of primers and probes is
performed in a speciﬁc reaction to avoid bias and favouring
against other respiratory viruses. Our rhinovirus PCR has
been optimized during recent years based on the available
genetic information, in particular regarding species C. By re-
optimizing the assay with new primers and probes, together
with the use of Invitrogen SuperScript enzymes, we detected
retrospectively more HRV-positive samples at a lower cycle
threshold (Ct) value. To ensure that these HRVs were not
enteroviruses, all samples were sequenced. We only detected
HRV, eventually 99 serotypes, as well as enterovirus 68, which
is genetically identical to HRV.
The Ct value (the number of ampliﬁcation cycles needed for
a PCR to become positive) was used as relative estimate for
the amount of HRV present in the samples.
TABLE 1. Primers and probes for HRV detection used in this
study
Primers/probes Sequence (5′? 3′) Positiona Tm
Rhino-fwdB-mod-TM GGTGTGAAGACTCGCATGTGC 408–427 60.1
Rhino-fwdA-mod-TM GGTGTGAAGAGCCCCGTGTG 408–426 62.4
Rhino-fwd-C-TM GGTGTGAAGAGCCNANTGYGCTC 408–429 58.9
Rhino-fwd-D-TM GGTGYGAAGANCCNANTGTGC 408–427 58.9
Rhino-fwd-E-TM GGTGTGAAGACYTGCATGTGC 408–427 57.9
Rhino-fwd-F-TM GGTGTGAAGAGYCNCGTGTGCT 408–428 58.1
Rhino-rev3 CCAAAGTAGTYGGTYCCRTCCC 523–544 58.4
Rhino-Probe-TM TCCTCCGGCCCCTGAATGCG 438–457 70.2
Rhino-Probe3 TCCTCCGGCCCCTGAATGTGG 438–458 69.1
Tm, melting temperature.
aPrimer positions are given according to the orientation of the primer; numbers
are given according to an HRV-A16 reference strain (GenBank no. L24917).
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Characterization of HRVwas carried out by ampliﬁcation and
sequencing of a 549 nucleotide fragment spanning the hyper-
variable part of the 5′NTR, the entire VP4 gene and the 5′
terminus of the VP2 gene as described before [8,9]. For
phylogenetic analysis a fragment of 395–401 bpwas aligned with
Clustal W 2.0 and phylogenetic trees were constructed by the
neighbour-joining method using MEGA 4.0 with the maximum
likelihood model and complete deletion for missing data. The
HRV sequences derived from this work have been submitted to
GenBank (accession numbers JQ042307-JQ042680).
Data analysis
For data analysis, the ﬁrst respiratory sample of each episode of
infection was included. An episode of infection, or disease
episode, was deﬁned as a time period starting with a ﬁrst day of
illness and ending with discharge from the hospital or resolution
of clinical symptoms, during which a respiratory sample was
taken for viral diagnostics. Statistical analyses were performed
using SPSS software version 20.0, (IBM, Armonk, NY, USA). For
normally distributed continuous variables, parametric tests
were used (Student t-test). The distribution of categorical
variables in comparison groups was analysed using the chi-
squared test. The association of HRV with chronic underlying
illness and symptoms was determined using binary and multi-
nomial logistic regression (with no infection, HRV mono-
infection, HRV mixed infection and other respiratory infection
as the dependent variable). A two-sided p-value <0.05 was
considered statistically signiﬁcant.
Results
Patients’ characteristics
From October 2009 till January 2011, 644 unique patients
were included, with 904 disease episodes; 366 (57%) were
male and 278 (43%) female. Characteristics of the patients with
no virus detected (n = 242, with 341 disease episodes), those
with only HRV (n = 162, 254 disease episodes) and those with
another respiratory virus than HRV (n = 157, 195 disease
episodes) are summarized in Table 2. In 83 patients (111
disease episodes), mixed infection of HRV with one or more
other respiratory viruses was found, most frequently adeno-
virus (37 episodes), RSV-A/B (35 episodes), bocavirus (20
episodes) and inﬂuenza A virus (11 episodes). These patients
did not differ signiﬁcantly from the ones with HRV mono-
infection (Table 2).
Patients with HRV infection had more underlying pulmonary
illness, mainly caused by asthma (39%) or congenital pulmonary
illness/anatomical malformations (44%), compared with PCR-
negative patients (p 0.01) or patients with another respiratory
virus than HRV (p 0.007).
Although the majority of patients were under the age of
5 years (80%), the prevalence of underlying illness was
signiﬁcantly higher in patients older than 5 years: in patients
with HRV mono-infection, 86% had co-morbidities, compared
with 64% in those under 5 (p 0.03); for PCR negatives, this was
83% vs. 56% (p 0.001); and in patients with another respiratory
virus, 70% had a chronic underlying disease, compared with
38% in those under 5 (p 0.002). These differences in preva-
lence of chronic underlying disease were mainly caused by a
signiﬁcantly higher prevalence of chronic respiratory disease in
the older age category (data not shown).
Clinical symptoms
To determine the relationship between HRV and clinical
symptoms, PCR-negative disease episodes were compared with
those with an HRV mono-infection. Because patients with HRV
had signiﬁcantly more chronic respiratory disease, we stratiﬁed
disease episodes for this underlying condition. HRV-positive
TABLE 2. Characteristics of patients with no respiratory virus detected (PCR negative), with HRVmono- or mixed infection and
with a respiratory virus other than HRV
PCR negative,
N = 242 (%)
HRV mono-infection,
N = 162 (%)
HRV mixed infection,
N = 83 (%)
Other respiratory
virus, N = 157 (%)
Sex
M 135 (55.8) 92 (56.8) 51 (61.4) 88 (56.1)
F 107 (44.2) 70 (43.2) 32 (38.6) 69 (43.9)
Age (months)
Mean 31.6 32.7 24.2 36.6
Median 1.0a 11.0 13.0 13.0
Underlying illness 142 (58.7) 108 (66.7)b 45 (54.2) 69 (43.9)
Pulmonary 52 (21.5) 54 (33.3)c 19 (22.9) 31 (19.7)
Cardiovascular 50 (20.7) 37 (22.8) 12 (14.4) 15 (9.6)d
Gastro-intestinal 33 (13.6) 14 (8.6) 8 (9.6) 8 (5.1)
Neurology 21 (8.7) 15 (9.3) 7 (8.4) 13 (8.2)
Immune suppressione 36 (14.9) 36 (22.2) 11 (13.3) 14 (8.9)
ap <0.0001.
bHRV mono-infection vs. other virus: p <0.001.
cHRV mono-infection vs. PCR negative p 0.01, vs. other virus p 0.007.
dOther virus vs. PCR negative p 0.003, other virus vs. HRV mono-infection p 0.001.
eMalignancy, transplantation, use of immune-suppressive therapy.
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patientswho also had a chronic respiratory disease, experienced
signiﬁcantly more cough, shortness of breath and a need for
oxygen compared with PCR negatives. However, in HRV-
positive patients without an underlying pulmonary illness, only
cough and fever were signiﬁcantly more present (Table 3).
In multivariate analysis, the presence of a chronic respira-
tory disease remained positively associated with HRV mono-
infection (OR, 2.06; CI, 1.43–2.97). This association was unique
for HRV mono-infections and was not found for HRV mixed
infections or other respiratory viral infections. Besides, in
patients with a chronic respiratory illness a need for oxygen
was exclusively related to HRV detection (odds ratio 3 for
HRV mono-infection, and 3.3 for mixed infection). Cough and
shortness of breath were equally strongly associated with the
detection of other respiratory viruses as with HRV (Table 4).
Patients with an HRV infection were more often diagnosed
with an exacerbation of asthma compared with PCR negatives
and patients with another respiratory virus, although the
difference with the latter group was not statistically signiﬁcant
(Table 5). In contrast, pneumonia and bronchiolitis were more
often associated with the detection of respiratory viruses
other than HRV.
The median length of stay in the hospital was signiﬁcantly
shorter for patients who had any respiratory virus compared
with patients with no virus (7 days vs. 25 days, p <0.001).
Also, patients with HRV had to stay longer in the hospital
compared with patients with another respiratory virus
(median length of stay 11 days vs. 6 days, p <0.001).
The median Ct value of HRV in HRV mono-infection was
24, signiﬁcantly lower than the median Ct value of HRV in HRV
mixed infections (28, p <0.001). However, we found no
relationship between the presence of symptoms and the
relative amount of virus in the samples.
Bacteriology and antibiotic use
Antibiotic use did not differ between the three patient groups
(in 52% of PCR negatives, 50% of those with HRV and 53%
with another respiratory virus, antibiotics were given). Also,
the duration of antibiotic therapy was comparable (median
duration of 7 days). In more than 60% of the disease episodes,
no bacteriological culture was recorded around the time the
virological sample was taken. When bacteriological cultures
were taken, signiﬁcantly more H. inﬂuenzae was found in
patients with HRV (17.4%, p 0.04) and in patients with another
respiratory virus (19.4%, p 0.02) compared with the patients
who had no respiratory virus detected (3.6%). S. pneumoniae
was more often found in patients with another respiratory
virus (19.4%) than in patients with HRV (2.2%, p 0.02). The use
of antibiotics was strongly associated with the clinical diagnosis
of pneumonia and the submission of samples for bacteriological
culture: antibiotics were prescribed in 94% of the patients with
pneumonia and in 75% of patients who had samples collected
for bacteriological culture (both p <0.001). However, the
outcome of the bacteriological culture (positive or negative)
did not inﬂuence the use of antibiotics (p 0.5), nor did the
presence of a chronic underlying illness (p 0.6).
HRV characterization
HRV was found throughout the study period, with the least
frequent detection during February, July and August 2010 and
peaks in spring (2010) and autumn (2009 and 2010) (Fig. 1).
However, during the winter period (December and January)
HRV was detected in 40–60% of the samples positive for
respiratory viruses.
Sequence analysis of HRV was possible in 303 out of 365
HRV-positive disease episodes; 221 episodes with HRV mono-
infection and 82 with HRV mixed infection. The reason for
unsuccessful sequence analysis was the low amount of HRV
present in the samples.
Overall, 99 different serotypes were detected, most often
species HRV-A (47%) and HRV-C (39%) (Fig. 2). In 12% of the
episodes, HRVs were detected belonging to species HRV-B.
We did not observe a trend in circulating serotypes. Almost 50
patients were identiﬁed with serial infections with different
TABLE 3. Clinical symptoms in disease episodes of patients with HRV mono-infection compared with PCR-negative patients
Symptoms
Pulmonary underlying illness No pulmonary underlying illness
PCR negative,
N = 83 episodes (%)
HRV mono-infection,
N = 98 episodes (%)
PCR negative,
N = 238 episodes (%)
HRV mono-infection,
N = 139 episodes (%)
Fever 29 (34.9) 48 (49.0) 111 (46.6) 82 (59.0)a
Cough 13 (15.7) 38 (38.8)b 28 (11.8) 35 (25.2)c
Dyspnoea 18 (21.7) 54 (55.1)d 53 (22.3) 34 (24.5)
Diarrhoea 4 (4.8) 12 (12.2) 27 (11.3) 24 (17.3)
Vomiting 6 (7.2) 12 (12.2) 27 (11.3) 19 (13.7)
Oxygen need 31 (37.3) 62 (63.3)b 57 (23.9) 29 (20.9)
Mechanical ventilation 34 (41.0) 30 (30.6) 91 (38.2) 40 (28.8)
ap 0.02 (HRV positives vs. PCR negatives in patients with no underlying pulmonary illness).
bp 0.001 (HRV positives vs. PCR negatives in patients with underlying pulmonary illness).
cp 0.001(HRV positives vs. PCR negatives in patients with no underlying pulmonary illness).
dp <0.001 (HRV positives vs. PCR negatives in patients with underlying pulmonary illness).
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serotypes or with different species. Three patients had
detection of serotypes belonging to HRV-A, HRV-B and
HRV-C consecutively.
In patients with HRV-B, more underlying pulmonary illness
was present (54%) compared with those with HRV-A and
HRV-C (32% and 39%), although the difference was only
statistically signiﬁcant for the comparison of HRV-B with HRV-
A (p 0.045). No signiﬁcant differences were seen in clinical
symptoms related to the species of HRV, except for the need
for oxygen, which was more present in patients with HRV-B
(p 0.012). Patients with HRV-C had a shorter duration of stay
in the hospital than patients with HRV-A (median 6 days vs.
10 days for HRV-A, p 0.009) and HRV-B (median 16 days,
p 0.008).
Nosocomial infection
Based on epidemiological data (ﬁrst day of illness in relation to
admission to the hospital), hospital-acquired infection was
present in 81 out of 365 HRV-positive episodes (22%), with a
ﬁrst day of illness ranging from 3 to 242 days after admission.
In 69 of 81 episodes (85.2%) HRV was detected as a mono-
infection, compared with 179 out of 273 (66%) community-
acquired HRV infections (p <0.001). Even when the deﬁnition
of hospital-acquired infection was adjusted to a ﬁrst day of
illness 5 days or more after admission, still 20% of the HRV-
positive disease episodes were nosocomial related. No
differences were observed in the age distribution in commu-
nity and hospital-acquired HRV infections. Although HRV-B
was the least frequently detected HRV species, equal propor-
tions of HRV-A and HRV-B infection were hospital acquired
(33.3% resp. 38.5%), while HRV-C was in only 18.0% of the
HRV-positive episodes acquired during hospitalization. Due to
the small number of HRV-B infections, these differences did
not reach statistical signiﬁcance.
Using phylogenetic analysis, 41 clusters of three or more
isolates with identical sequences could be identiﬁed during this
study period. Nine of the 41 clusters were formed by three or
more consecutively taken isolates from one patient per
cluster. Two clusters of EV68 were identiﬁed, corresponding
with an upsurge of EV68-related respiratory tract infections
detected in the autumn of 2010, as described previously [8].
We collected more detailed information about the wards
patients were admitted to, ﬁrst day of illness, date of admission
and sample date in the remaining 30 clusters, to see whether
the clustering of patients based on the virological analysis was
supported by epidemiological data. In eight clusters epidemi-
ological information was suggestive of transmission of HRV on
the same hospital ward (Fig. 2).
Discussion
In this large hospital-based prospective cohort study into viral
respiratory infections in children, HRV was the most com-
monly detected respiratory virus, in the majority as HRV
TABLE 5. Clinical diagnosis in patients with HRV compared
with patients who were PCR negative or who had another
respiratory virus (% of episodes)
Clinical diagnosis
PCR
negative (%)
HRV
infection (%)
Other
respiratory virus (%)
Upper respiratory
tract infection
13.5 52.8a 49.7a
Otitis media 0.9 1.2 3.6
Exacerbation asthma 0.6 5.1b 1.0
Bronchiolitis 0.9 2.0 15.4c
Pneumonia 10.9 12.2 18.5d
ap <0.001 compared with PCR negative.
bp 0.008 compared with PCR negative, p 0.12 compared with other respiratory
virus.
cp <0.001 compared with PCR negative and HRV positive.
dp 0.02 compared with PCR negative, p 0.04 compared with HRV positive.
0
20
40
60
80
100
120
140
OC
T 0
9
NO
V 0
9
DE
C 0
9
JA
N 
10
FE
B 1
0
M
AR
 10
AP
R 1
0
M
AY
 10
JU
N1
0
JU
L 1
0
AU
G 
10
SE
P 1
0
NO
V 1
0
DE
C 1
0
Non-HRV positive
HRV mixed infection 
HRV mono-infection
Number of specimen 
OC
T 1
0
FIG. 1. Monthly distribution of the number of respiratory specimens
taken in our patient population, the number of HRV detections (either
as mono-infection or mixed infection) and the number of detected
respiratory viruses other than HRV (non-HRV positive).
TABLE 4. Association of clinical symptoms with the detec-
tion of HRV and other respiratory viruses in patients with
chronic respiratory disease
Symptoms
HRV
mono-infection
(OR, 95% CI)
HRV
co-detection
(OR, 95% CI)
Other respiratory
virus (OR, 95% CI)
Fever 1.37 (0.69–2.71) 2.62 (1.02–6.70) 4.19 (1.68–10.42)
Cough 2.52 (1.17–5.4) 2.7 (1.03–7.16) 3.77 (1.53–9.28)
Dyspnoea 4.12 (2.10–8.09) 6.74 (2.68–16.94) 6.13 (2.60–14.44)
Diarrhea 2.04 (0.55–7.57) 1.43 (0.28–7.25) 1.36 (0.31–5.94)
Vomiting 1.33 (0.43–4.14) 1.60 (0.39–6.58) 2.50 (0.72–8.72)
Need for
oxygen
3.02 (1.63–5.58) 3.29 (1.38–7.84) 1.39 (0.66–2.92)
Mechanical
ventilation
0.63 (0.33–1.19) 0.19 (0.06–0.61) 0.46 (0.20–1.05)
OR, odds ratio; CI, 95% conﬁdence interval.
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mono-infections. Also, high nosocomial infection rates were
observed. HRV infection was associated with substantial
respiratory illness, especially among children with pre-existing
pulmonary disease.
Although the association of HRV with asthma has been well
established in recent years, the occurrence of HRV infections
in our study was associated with chronic respiratory illness in
general [5,10,11]. Whether these children are more vulnerable
to the acquisition of HRV, or whether they have more
symptomatic illness related to HRV, remains to be elucidated.
In patients with a chronic respiratory condition, only the need
for oxygen was predictive for HRV; cough and shortness of
breath were not only associated with the detection of HRV,
but also with the detection of other respiratory viruses. Thus,
respiratory symptoms alone are not sufﬁcient to predict the
presence of an HRV infection.
Several studies tried to relate viral load to the presence or
absence of symptoms. Although a positive relationship
between a higher viral load and more (serious) respiratory
symptoms has been reported, others were not able to
reproduce these ﬁndings [11–15]. Adequate quantiﬁcation of
HRV in respiratory samples is currently limited by several
factors, as addressed in recent reports [16,17]. One major
limitation is the lack of a reference standard for the
quantiﬁcation of all HRV types. Secondly, HRV viral load is
affected by the sample type and the method of collection and
detection [18]. Thus, although in our study no relationship
between the relative amount of virus (expressed as Ct value)
and the presence of clinical symptoms could be demonstrated,
the interpretation of the Ct value in relation to severity of
illness remains to be determined and is probably, with the
current limitations in quantiﬁcation of HRV, hardly feasible.
HRV was detected year round, with the least frequent
detection in February, July and August 2010. Although peaks in
detection were seen in autumn and spring, as is known from
the literature, HRV was still detected in around half of the
samples positive for respiratory viruses in the remaining
months, including the winter period [6,17,19]. However, as
most studies suggest variation of HRV detection by season and
year, our study period may well have been too short to fully
understand the seasonality of HRV in our hospital.
Antibiotic use and duration of antibiotic therapy did not
differ between the patients with and without a respiratory viral
infection, suggesting that the decision to prescribe antibiotics
was not inﬂuenced by the outcome of viral diagnostics, as has
been observed elsewhere [20,21]. This might be explained by
concerns over getting a bacterial co-infection. Indeed, antibi-
otic use was associated with submission of samples for
bacteriological culture, assuming a suspicion of bacterial
infection in those patients. However, although bacteria known
FIG. 2. Phylogenetic tree of detected
HRV serotypes in this study. In red are
the clusters of infection based on epide-
miological and virological information. In
bold are the clusters of EV68, as described
before [8].
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to cause (secondary) respiratory infections in infants were
more frequently cultured in patients with a respiratory viral
infection compared with patients with no viral infection
(H. inﬂuenzae, S. pneumoniae), the outcome of the bacterio-
logical cultures did not inﬂuence the use of antibiotics. Because
the collection of samples for bacteriological culture was not
standardized, but dependent on the judgement of the clinician,
and carried out in only a minority of patients, these results
might have been biased and more studies are needed to
conﬁrm our ﬁndings.
The high prevalence of co-morbidities and the associated
vulnerability of our patient population could have lowered the
threshold for prescribing antibiotics. However, we did not ﬁnd
a positive association between antibiotic therapy and the
presence of a chronic underlying illness. We did ﬁnd a strong
correlation between antibiotic therapy and pneumonia as the
clinical diagnosis. This may suggest that clinical signs and
symptoms were more important in deciding on antibiotic
therapy than patient characteristics and microbiological
results.
Sequence analysis revealed a high diversity of different HRV
serotypes, as reported before [22–24]. In our population,
species HRV-A and HRV-C were detected in equal amounts,
and dominated over HRV-B. We observed no species-speciﬁc
pattern of clinical illness, except that HRV-B was associated
with a higher need for oxygen. Besides, patients with HRV-A
and HRV-B had to stay in the hospital signiﬁcantly longer than
patients with HRV-C. Until now, studies that addressed the
relationship between species and severity of illness reported
HRV-B as being the least virulent compared with HRV-A and
HRV-C [6,17]. However, recently, Miller et al. also showed
that patients with HRV-B were more likely to require
supplemental oxygen and had a longer duration of stay in the
hospital [19]. Also, patients with HRV-B tended to have higher
disease severity scores. The reason for the different observa-
tions regarding HRV-B-associated severity of illness is not
clear. Our study and the study of Miller et al. included
hospitalized children, whereas in a recent study by Lee et al.,
who showed a clear distinction in severity of illness between
HRV-A/C and HRV-B, the majority of patients were not
admitted to the hospital [6]. Also, we observed a tendency for
more chronic respiratory illness in patients with an HRV-B
infection, possibly explaining the higher need for oxygen.
These ﬁndings may suggest that HRV-B is associated with
either asymptomatic carriage or mild respiratory disease, and
that host factors such as pre-existing pulmonary disease
contribute to more serious, symptomatic respiratory illness
caused by HRV-B.
One of the most remarkable ﬁndings of our study is the
frequency of hospital-acquired HRV infection: in more than
20% of the HRV-positive disease episodes, patients had a ﬁrst
day of illness more than 2 days after admission to the hospital.
Phylogenetic analysis revealed several clusters of HRV with
identical sequences; in more than 25% of these clusters
epidemiological information was suggestive of transmission of
the virus on speciﬁc wards. Although HRV-B is the least
frequently found species in our study, almost 40% of HRV-B
infections are acquired in the hospital. This suggests that the
hospital environment is for some reason more favourable for
transmission of HRV-B. Also, if HRV-B is indeed associated
with asymptomatic carriage or mild respiratory disease, this
would facilitate transmission within the hospital, only causing
clear respiratory symptoms in patients with pre-existing
pulmonary illness.
Outbreaks of rhinovirus infections have been described in
long-term care facilities, but very little is known about the
frequency of hospital-acquired HRV infection [25,26]. Trans-
mission mainly occurs via droplets or contact and although
measures to prevent transmission were taken the moment
HRV was detected in respiratory samples, infectiousness is
probably highest in the early stages of disease, before the
outcome of diagnostic tests is available and thus before
infection control measures were taken. These ﬁndings advo-
cate the implementation of infection control measures driven
by the presence of respiratory symptoms instead of the
outcome of a laboratory test. However, further investigations
are needed to determine the contribution of healthcare
workers, other patients and visitors in nosocomial transmis-
sion of HRV.
The present study has some limitations. Being a tertiary
referral hospital could have biased our ﬁndings towards more
serious illness, as is reﬂected by the characteristics of the
included patients: more than 50% of the children had a chronic
underlying illness, and even in the ones that had no respiratory
virus detected, signs and symptoms of serious illness were
present (e.g. mechanical ventilation). Furthermore, information
on bacterial co-infection was based on cultures taken just
around the time the viral sample was taken. Information on the
presence of bacterial pathogens outside this timeframe was
not included. Also, we had no information about the presence
of so-called atypical bacterial pathogens (e.g Mycoplasma or
Chlamydophila). However, given the high prevalence of HRV
infection in our study population and the expected low
prevalence of atypical pathogens, we assume that this limitation
does not inﬂuence the main conclusions of our study [20,21].
In conclusion, HRVs are capable of causing serious respi-
ratory disease in children hospitalized in a tertiary referral
hospital, particularly in patients with pulmonary co-morbidi-
ties. Nosocomial infection occurs frequently. Most notably,
HRV species B may have features that facilitate transmission
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within the hospital. Although antiviral therapy is not yet
available for patients infected with HRV, the detection and
identiﬁcation of these viruses could help in explaining respi-
ratory illness. Also, identifying HRV provides opportunities for
implementing timely and accurate infection control measures
to prevent further transmission. Our study illustrates the value
of sequence analysis not only in gaining insight into the genetic
diversity of rhinoviruses, but also as a tool in deﬁning
transmission routes within the hospital and in the detection
of sources of nosocomial infection.
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